Notable Labs raises $10M in series A

On Sept. 6, Notable Labs Inc. (San Francisco, Calif.) raised $10 million in a series A round which it will use to develop its drug testing service to identify personalized treatment options for blood cancer patients. The round was led by Builders VC; undisclosed existing investors also participated. Builders VC's Jim Kim will be joining Notable's board.

Notable previously raised $7 million in seed funding in the form of convertible notes from Eleven Two Capital, First Round Capital, Founder’s Fund, Fuel Capital, Lightspeed, Upside Partnership and Y Combinator...